Global Transplant Diagnostics Market Report (2018-2023) - The Molecular Assay Technology Segment is Expected to Account for the Largest Share of the Market

World News: . []

Dublin, July 12, 2018 (GLOBE NEWSWIRE) -- The report has been added to offering.

The global transplant diagnostics market is projected to reach USD 4.91 billion by 2023 from USD 3.44 billion in 2018, at a CAGR of 7.4%.

Increasing number of transplantation procedures, technological advancements in the field of transplant diagnostics, increasing public-private funding for target research activities, and growing burden of infectious diseases are some of the factors responsible for the growth of this market. However, the high procedural cost for next-generation sequencing (NGS) and PCR-based diagnostics assays and limited availability of reimbursements for target procedures are expected to limit the optimal adoption of transplant diagnostics during the forecast period.

This report broadly segments the market into technology, product, transplant type, application, end user, and region. On the basis of technology, the market is segmented into molecular and non-molecular assay technologies. In 2018, the molecular assay technology segment is expected to account for the largest share of the market. This can be attributed to the expansion in the distribution network of key transplant diagnostic manufacturers across emerging countries (through strategic acquisitions, collaborations, and strengthening manufacturing capabilities) and increasing private funding to develop innovative transplant diagnostic products.Based on product & service, the market is categorized into reagents & consumables, instruments, and software & services. The reagents & consumables segment accounted for the largest share of the market in 2018. Growing adoption of transplant diagnostic techniques in related research studies and rising number of organ transplantation procedures across major markets are the key factors supporting the growth of the transplant diagnostics market for reagents and consumables.On the basis of transplant type, the market is categorized into solid organ, stem cell, and soft tissue transplantation. The solid organ transplantation segment accounted for the largest share of the market in 2018. Increasing number of solid organ transplantation procedures, supportive government regulations to augment organ donations across major healthcare markets, and rising number of chronic diseases/disorders that leads to transplantation are the key factors supporting the growth of the market for solid organ transplantation.Based on application, the market is categorized into diagnostic and research applications. The diagnostic applications segment accounted for the largest share of the market in 2018. The rising incidence of chronic diseases (that often lead to transplantation in critical and terminal patients) and greater risk of genetic disorders and pathogenic infections after transplantation (due to weaker immunity in geriatric recipients and discovery of novel biomarkers to identify genetic disorders) are the key factors supporting the growth of the transplant diagnostics market for diagnostic applications.Based on end user, the market is segmented into three categories, namely, independent reference laboratories, hospitals and transplant centers, and research laboratories & academic institutes. In 2018, the independent reference laboratories segment is expected to account for the largest share of the market due to increasing global demand for infectious disease diagnosis and tissue typing during donor-recipient profiling/cross-matching, growing number of organ transplantation procedures, and growing inauguration & accreditation of diagnostic laboratories across emerging as well as developed countries.This report covers the market across four major regions, namely, North America, Europe, Asia Pacific, and the RoW. North America is expected to command the largest share of the market in 2018. The large share of North America in the global transplant diagnostics market is attributed to the high budgetary allocation for healthcare expenditure, large volume of organ transplantation procedures performed in the region, and technological advancements in the field of transplant diagnostics.

1 Introduction1.1 Objectives of the Study1.2 Market Definition1.3 Market Scope1.3.1 Markets Covered1.3.2 Geographic Scope1.3.3 Years Considered for the Study1.4 Currency Used for the Study1.5 Major Market Stakeholders2 Research Methodology2.1 Research Data2.1.1 Secondary Data2.1.2 Primary Data2.2 Market Size Estimation2.2.1 Product-Based Market Estimation2.2.2 Procedure Based Market Estimation2.2.3 Primary Research Validation2.3 Data Triangulation2.4 Research Assumptions2.5 Research Limitations3 Executive Summary4 Premium Insights4.1 Transplant Diagnostics Market Overview4.2 Market, By Technology4.3 Regional Analysis: Market, By Application4.4 Asia Pacific: Market, By End User, 20184.5 Regional Analysis: Market, By Product & Service4.6 Regional Analysis: Market, By Transplant Type4.7 Transplant Diagnostics Market, By Country5 Market Overview5.1 Introduction5.2 Market Dynamics5.2.1 Key Market Drivers5.2.1.1 Increasing Number of Transplant Procedures5.2.1.2 Technological Advancements in the Field of Transplant Diagnostics5.2.1.3 Increasing Public-Private Funding for Target Research Activities5.2.1.4 Growing Burden of Infectious Diseases5.2.2 Key Market Restraints5.2.2.1 High Procedural Cost of NGS and PCR-Based Diagnostic Assays5.2.2.2 Limited Reimbursements for Target Procedures5.2.3 Key Market Opportunities5.2.3.1 Rising Adoption of Cross-Matching and Chimerism Testing During Pre- & Post-Transplantation5.2.3.2 Increasing Public Awareness About Organ Donation and Transplantation Across Emerging Countries5.2.4 Key Market Challenges5.2.4.1 Significant Gap Between the Number of Organ Donors and Organs Required Annually5.2.4.2 Procedural and Technical Limitations Associated With Donor-Recipient Screening6 Transplant Diagnostics Market, By Product and Services6.1 Introduction6.2 Reagents and Consumables6.3 Instruments6.4 Software and Services7 Transplant Diagnostics Market, By Technology7.1 Introduction7.2 Molecular Assays7.2.1 PCR-Based Molecular Assays7.2.1.1 Real-Time PCR7.2.1.2 Sequence-Specific Primer-PCR7.2.1.3 Sequence-Specific Oligonucleotide-PCR7.2.1.4 Other PCR-Based Molecular Assays7.2.2 Sequencing-Based Molecular Assays7.2.2.1 Sanger Sequencing7.2.2.2 Next-Generation Sequencing7.2.2.3 Other Sequencing Molecular Assays7.3 Non-Molecular Assays8 Transplant Diagnostics Market, By Transplant Type8.1 Introduction8.2 Solid Organ Transplantation8.2.1 Kidney Transplantation8.2.2 Liver Transplantation8.2.3 Heart Transplantation8.2.4 Lung Transplantation8.2.5 Pancreas Transplantation8.2.6 Other Organ Transplantations8.3 Stem Cell Transplantation8.4 Soft Tissue Transplantation9 Transplant Diagnostics Market, By Application9.1 Introduction9.2 Diagnostic Applications9.2.1 Pre-Transplantation Diagnostics9.2.1.1 Infectious Disease Testing9.2.1.2 Histocompatibility Testing9.2.1.3 Blood Profiling9.2.2 Post-Transplantation Diagnostics9.3 Research Applications10 Transplant Diagnostics Market, By End User10.1 Introduction10.2 Independent Reference Laboratories10.3 Hospitals & Transplant Centers10.4 Research Laboratories & Academic Institutes11 Transplant Diagnostics Market, By Region11.1 Introduction11.2 North America11.2.1 US11.2.2 Canada11.3 Europe11.3.1 Germany11.3.2 UK11.3.3 France11.3.4 Rest of Europe11.4 Asia Pacific11.4.1 Japan11.4.2 China11.4.3 India11.4.4 Rest of Asia Pacific11.5 Rest of the World12 Competitive Landscape12.1 Overview12.2 Market Share Analysis12.3 Competitive Scenario12.3.1 Key Product Launches and Enhancements (2014 to 2018)12.3.2 Key Agreements, Partnerships, and Collaborations (2014 to 2018)12.3.3 Major Acquisitions (2014 to 2018)12.3.4 Key Expansions (2014 to 2018)13 Company Profiles13.1 Introduction13.2 Becton, Dickinson and Company13.3 Biofortuna13.4 Biomrieux SA13.5 Bio-Rad Laboratories13.6 Caredx13.7 F. Hoffman-La Roche Limited13.8 Gendx13.9 Hologic13.10 Illumina13.11 Immucor13.12 Luminex13.13 Merck KGaA13.14 Omixon13.15 Qiagen13.16 Thermo Fisher Scientific

For more information about this report visit

Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Diagnostics

More news and information about Research and Markets

Published By:

Globe Newswire: 09:31 GMT Thursday 12th July 2018

Published: .

Search for other references to "global" on SPi News

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us